Among 49 RTKs, IGF-1R phosphorylation was increased after osimertinib exposure in AXL-low-expressing tumor cell lines, but not in AXL-high-expressing tumor cell lines (Fig. 1e). The gene discussed is IGF1R; the disease is neoplasm.